LUNG CANCER 101

225 topics in this forum

1. Dr. Suresh Ramalingam Reviews the “Phases” of Clinical Resea

   By NikoleV, February 15, 2013
   • 0 replies
   • 1.4k views
   • 
   • NikoleV
   • February 15, 2013

2. “Mixed Response” in Lung Cancer: What Should We Do, and What

   By NikoleV, January 11, 2013
   • 0 replies
   • 1.3k views
   • 
   • NikoleV
   • January 11, 2013

3. How should we use serum tumor markers, if ever, in managing

   By NikoleV, January 9, 2013
   • 0 replies
   • 945 views
   • 
   • NikoleV
   • January 9, 2013

4. My evolving views on molecular testing in advanced NSCLC

   By NikoleV, January 3, 2013
   • 0 replies
   • 950 views
   • 
   • NikoleV
   • January 3, 2013

5. Is there an age cap for chemo?

   By NikoleV, January 3, 2013
   • 0 replies
   • 905 views
   • 
   • NikoleV
   • January 3, 2013

6. Why Don’t We Routinely Use Two Drug Combinations for Previou

   By NikoleV, December 17, 2012
   • 0 replies
   • 1.2k views
   • 
   • NikoleV
   • December 17, 2012

7. Dr. Aisner’s Glimpse into the Future of Molecular Marker Tes

   By NikoleV, December 17, 2012
   • 0 replies
   • 991 views
   • 
   • NikoleV
   • December 17, 2012

8. Dr. Dara Aisner Introducing Molecular Pathology & Challenges

   By NikoleV, December 10, 2012
   • 0 replies
   • 990 views
   • 
   • NikoleV
   • December 10, 2012

9. Dr. Mehta Podcasts on New Technologies on Radiation for Lung

   By NikoleV, December 3, 2012
   • 0 replies
   • 1k views
   • 
   • NikoleV
   • December 3, 2012

10. Is Rash a Critical Predictor of Benefit with EGFR Inhibitors

    By NikoleV, November 26, 2012
    • 0 replies
    • 1k views
    • 
    • NikoleV
    • November 26, 2012

11. Is there an upper age cap on chemotherapy for lung cancer?

    By NikoleV, November 26, 2012
    • 0 replies
    • 843 views
    • 
    • NikoleV
    • November 26, 2012

12. Why Add Chemo with Surgery and/or Radiation?

    By NikoleV, November 19, 2012
    • 0 replies
    • 1k views
    • 
    • NikoleV
    • November 19, 2012

13. Early Evidence Helping to Define a Role for Stereotactic Rad

    By NikoleV, November 15, 2012
    • 0 replies
    • 1k views
    • 
    • NikoleV
    • November 15, 2012

14. Do Patients Want Their Oncologist to be a Teacher or a Cheer

    By NikoleV, November 15, 2012
    • 0 replies
    • 822 views
    • 
    • NikoleV
    • November 15, 2012

15. Dr. Vivek Mehta on Refining Radiation for Lung Cancer

    By NikoleV, November 5, 2012
    • 0 replies
    • 981 views
    • 
    • NikoleV
    • November 5, 2012

16. Dr. Silvestri, Pulmonologist, on Pulmonary Complications of

    By NikoleV, October 30, 2012
    • 0 replies
    • 891 views
    • 
    • NikoleV
    • October 30, 2012

17. If Lung Cancer Screening Helps Some, Should We Screen Everyo

    By NikoleV, October 30, 2012
    • 0 replies
    • 798 views
    • 
    • NikoleV
    • October 30, 2012

18. Defining the Right Population for Lung Cancer Screening: Why

    By NikoleV, October 26, 2012
    • 0 replies
    • 847 views
    • 
    • NikoleV
    • October 26, 2012

19. Nexavar (Sorafenib) Fails in Overall Trial but Looks Favorab

    By NikoleV, October 19, 2012
    • 0 replies
    • 849 views
    • 
    • NikoleV
    • October 19, 2012

20. ASCO Lung Cancer Highlights: Question and Answer Session Pod

    By NikoleV, October 15, 2012
    • 0 replies
    • 869 views
    • 
    • NikoleV
    • October 15, 2012

21. Bavituximab: A Great Story that Turns Out Too Good to be Tru

    By NikoleV, October 15, 2012
    • 0 replies
    • 922 views
    • 
    • NikoleV
    • October 15, 2012

22. Molecular Targets in Lung Cancer: Not Just for Adenocarcinom

    By NikoleV, September 26, 2012
    • 0 replies
    • 897 views
    • 
    • NikoleV
    • September 26, 2012

23. ASCO 2012 Highlights: Exploring Adjuvant Tarceva for EGFR Mu

    By NikoleV, September 24, 2012
    • 0 replies
    • 871 views
    • 
    • NikoleV
    • September 24, 2012

24. ASCO 2012 Highlights: Breaking an Impasse for KRAS Mutation-

    By NikoleV, September 24, 2012
    • 0 replies
    • 856 views
    • 
    • NikoleV
    • September 24, 2012

25. Dr. Joel Neal on anti-PD-1 Immunotherapy and Afatinib for EG

    By NikoleV, September 24, 2012
    • 0 replies
    • 1.1k views
    • 
    • NikoleV
    • September 24, 2012